The role of OCTN2 in cancer remains unclear, however one hypothesis is that its expression may be reduced in cancers bringing about a reduction in carnitine transport and in turn having knock-on effects for mitochondrial fatty acid ß-oxidation [83]. This evidence concerns the gene SLC22A5 and cancer.